KELLY DENNIS: Open Payments
NPI 1386770246 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 23 payments from 11 companies in 2025. Trend: 2023 $182 · 2024 $409 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| Astellas Pharma US Inc | 7 | $109 |
| SHIELD THERAPEUTICS INC | 3 | $81 |
| Exeltis, USA Inc. | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Organon LLC | 2 | $28 |
| Hologic Sales and Service, LLC | 1 | $24 |
| ConvaTec Inc. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $14 |
Products named: TZIELD, Veozah, ACCRUFER, SLYND, NEXPLANON, GEMTESA, THINPREP 2000 PROCESSOR, AQUACEL AG+ EXTRA.
Industry payments across OK — which companies pay providers there.
